Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

Targeting Some Key Metalloproteinases by Nano-Naringenin and Amphora coffeaeformis as a Novel Strategy for Treatment of Osteoarthritis in Rats

pharmaceuticals | 2023

DOI: https://doi.org/10.3390/ph16020260

Two dimensional-QSAR and molecular dynamics studies of a selected class of aldoxime- and hydroxy-functionalized chalcones as monoamine oxidase-B inhibitors

journal of biomolecular structure and dynamics | 2022

DOI: https://doi.org/10.1080/07391102.2022.2146198

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders

pharmaceutics | 2022

DOI: https://doi.org/10.3390/pharmaceutics13060850

Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations

journal of enzyme inhibition and medicinal chemistry | 2022

DOI: https://doi.org/10.1080/14756366.2022.2080205

The nutraceutical properties and health benefits of pseudocereals: a comprehensive treatise

critical reviews in food science and nutrition | 2022

DOI: https://doi.org/10.1080/10408398.2022.2071205

The Chemical Profiling, Docking Study, and Antimicrobial and Antibiofilm Activities of the Endophytic fungi Aspergillus sp. AP5

molecules | 2022

DOI: https://doi.org/10.3390/molecules27051704

Targeting tumor cells with pyrazolo[3,4-d] pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms

arabian journal of chemistry | 2022

DOI: https://doi.org/10.1016/j.arabjc.2022.103781

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders

pharmaceutics | 2021

DOI: https://doi.org/10.3390/pharmaceutics13060850

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders

pharmaceutics | 2021

DOI: https://doi.org/10.3390/ pharmaceutics13060850